Despite high in-hospital mortality associated with acute respiratory distress syndrome (ARDS), there is no effective therapeutic strategy. We tested the hypothesis that combined melatonin-mitochondria treatment ameliorates 100% oxygen-induced ARDS in rats. Adult male Sprague-Dawley rats (n = 40) were equally categorized into normal controls, ARDS, ARDS-melatonin, ARDS with intravenous liver-derived mitochondria (1500 μg per rat 6 hr after ARDS induction), and ARDS receiving combined melatonin-mitochondria. The results showed that 22 hr after ARDS induction, oxygen saturation (saO2 ) was lowest in the ARDS group and highest in normal controls, significantly lower in ARDS-melatonin and ARDS-mitochondria than in combined melatonin-mitochondria group, and significantly lower in ARDS-mitochondria than in ARDS-melatonin group. Conversely, right ventricular systolic blood pressure and lung weight showed an opposite pattern compared with saO2 among all groups (all P < 0.001). Histological integrity of alveolar sacs showed a pattern identical to saO2 , whereas lung crowding score exhibited an opposite pattern (all P < 0.001). Albumin level and inflammatory cells (MPO+, CD40+, CD11b/c+) from bronchoalveolar lavage fluid showed a pattern opposite to saO2 (all P < 0.001). Protein expression of indices of inflammation (MMP-9, TNF-α, NF-κB), oxidative stress (oxidized protein, NO-1, NOX-2, NOX-4), apoptosis (mitochondrial Bax, cleaved caspase-3, and PARP), fibrosis (Smad3, TGF-β), mitochondrial damage (cytochrome C), and DNA damage (γ-H2AX+) exhibited an opposite pattern compared to saO2 in all groups, whereas protein (HO-1, NQO-1, GR, GPx) and cellular (HO-1+) expressions of antioxidants exhibited a progressively increased pattern from normal controls to ARDS combined melatonin-mitochondria group (all P < 0.001). In conclusion, combined melatonin-mitochondrial was superior to either treatment alone in attenuating ARDS in this rat model.

We have developed a new heptacyclic benzodi-(cyclopentadithiophene) (BDCPDT) unit, where 3,7-positions of the central benzo [1,2-b:4,5-b′]dithiophenes (BDT) subunit are covalently rigidified with 3-positons of the two external thiophenes by two carbon bridges, forming two external CPDT rings that share two thiophene rings with the central BDT core. The distannyl-BDCPDT building block was copolymerized with 1,3-dibromo-thieno[3,4-c]pyrrole-4,6-dione (TPD) by Stille polymerization to afford a new alternating donor−acceptor copolymer PBDCPDT-TPD. The implementation of forced planarization greatly suppresses the interannular twisting to extend the effective conjugated length and preserve the interactions between the donor and acceptor segments. The device using the PBDCPDT-TPD/PC 71 BM (1:3 in wt%) blend processed with dimethyl sulfoxide as an additive delivered a marked PCE of 6.6% which represents a significant enhancement compared to the device using the corresponding nonfused polymer analogue with a PCE of 0.2%.

Supplemental Digital Content is available in the text

A triarylamine-based crosslinked hole-transporting material is integrated with an ionic dopant to achieve high-performance PEDOT:PSS-free polymer solar cells.